Administration of a Next-Generation Probiotic Escherichia coli Nissle 1917-GLP-1 Alleviates Diabetes in Mice With Type 1 and Type 2 Diabetes

Administration of a Next-Generation Probiotic Escherichia coli Nissle 1917-GLP-1 Alleviates Diabetes in Mice With Type 1 and Type 2 Diabetes

Diabetes mellitus (DM) is a persistent and steadily progressing metabolic condition distinguished by unregulated high levels of blood glucose. GLP1 receptor agonists have recently gained recognition as first-line therapies in selected instances, as per the updated ADA guidelines, highlighting their...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jie Luo, Yilin Fang, Zhanghua Qi, Fengyang Cui, Hong Hu, Shengjie Li, Tingtao Chen, Hongyan Zhang
Format:	Article
Language:	English
Published:	Wiley 2025-01-01
Series:	Canadian Journal of Infectious Diseases and Medical Microbiology
Online Access:	http://dx.doi.org/10.1155/cjid/6675676
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluating the Effect on Total Daily Insulin Dose in Adult Patients with Type 1 Diabetes Managed with Metformin and/or GLP-1 or GLP-1/GIP Receptor Agonists
by: Mayeesha Ahmed, et al.
Published: (2025-02-01)

GLP-1 and SGLT2 Therapies in Type 2 Diabetes Mellitus. Cutting-Edge Approaches to Advancing Diabetes Care
by: Agnieszka Parfianowicz, et al.
Published: (2025-02-01)

Impact of Hospitalization on Continuation of SGLT2 Inhibitors and GLP-1 Receptor Agonists for Comorbidities in Patients with Type 2 Diabetes
by: Bethany Murphy, et al.
Published: (2025-01-01)

Liver Damage in Type 1 Diabetes Mellitus
by: A. O. Bueverov, et al.
Published: (2021-06-01)

Rett syndrome complicated by diabetes mellitus type 1
by: Yasutaka Kuniyoshi, et al.
Published: (2025-02-01)

The Effectiveness of Motivational Psychotherapy on Social-Emotional Competencies of Students with Type 1 Diabetes
by: Hossein Sahebdel, et al.
Published: (2025-01-01)

Fear of hypoglycemia in Italian mothers of children with type 1 diabetes: the mediating role of resilience
by: Paola Cardinali, et al.
Published: (2021-08-01)

Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli.
by: Danelle S Eto, et al.
Published: (2007-07-01)

Confounding Risk Factors in Developing Type 1 Diabetes Mellitus among Children and Adolescents at Sulaimani Chronic Diabetes Health Center
by: Pary Mohammad Azize, et al.
Published: (2021-07-01)

Metabolic control and its associated factors in type 1 diabetic people: longitudinal trajectory modeling
by: Zahra Khosravi, et al.
Published: (2025-02-01)

Targeting ferroptosis: opportunities and challenges of mesenchymal stem cell therapy for type 1 diabetes mellitus
by: Le Dai, et al.
Published: (2025-02-01)

Hospitalisation from seasonal influenza among persons with type 1 diabetes: a cohort study from the Swedish National Diabetes Register
by: Katarina Eeg-Olofsson, et al.
Published: (2025-02-01)

Adverse effects of GLP – 1 Receptor Agonists
by: Anna Kasprzak, et al.
Published: (2025-02-01)

The protective role of GLP-1 in neuro-ophthalmology
by: Sohum Sheth, et al.
Published: (2023-08-01)

Exploring proteomic immunoprofiles: common neurological and immunological pathways in multiple sclerosis and type 1 diabetes mellitus
by: Fátima Cano-Cano, et al.
Published: (2025-02-01)

Blood and bile lipid composition and the risk of gallstones at diabetes mellitus of the 1st and 2nd type
by: V. V. Tsukanov, et al.
Published: (2018-08-01)

We Are on the Verge of Breakthrough Cures for Type 1 Diabetes, but Who Are the 2 Million Americans Who Have It?
by: Rebecca Smith, et al.
Published: (2024-11-01)

Correlation Between Serum Uric Acid, Insulin and Hba1c In Type 2 Diabetes Mellitus
by: Maryam Imtiaz, et al.
Published: (2024-06-01)

Real-World HbA1c Changes Among Type 2 Diabetes Mellitus Patients Initiating Treatment With a 1.0 Mg Weekly Dose of Semaglutide for Diabetes
by: Noelle N. Gronroos, et al.
Published: (2024-11-01)

Long term cost-effectiveness analysis of IDegLira in the treatment of type 2 diabetes patients compared to GLP-1RA added to basal insulin after IDegLira entered the national reimbursement drug list in China.
by: Dunming Xiao, et al.
Published: (2025-01-01)

Plasma matrix metalloproteinases and tissue inhibitors of metalloproteinases explored in relation to the severity and progression of diabetic retinopathy in patients with type 1 diabetes: baseline and prospective analyses
by: Sven Hector, et al.
Published: (2024-08-01)

Foundational contributions of Svetlana Mojsov to the GLP-1 field
by: George Barany, et al.
Published: (2024-10-01)

Acute effects of physical exercise on cognitive function and neurotrophins in patients with type 1 diabetes: A systematic review
by: Emanuele Zanardo, et al.
Published: (2025-02-01)

Glycemic control in patients with type 1 diabetes mellitus affects periodontal health but not salivary status: An observational study
by: Paula de Oliveira Cunha, et al.
Published: (2024-07-01)

Association of Subclinical Hypothyroidism in Type 2 Diabetic Individuals
by: Noor ul ain, et al.
Published: (2025-02-01)

NUTRITION IN TYPE II DIABETES MELLITUS THE ELEPHANT IN THE ROOM
by: Peter Baillie
Published: (2024-10-01)

A prevalent caveolin-1 gene rs926198 variant is associated with type 2 diabetes mellitus in the Thai population
by: Metha Yaikwawong, et al.
Published: (2024-11-01)

Evaluation of care and clinical outcomes after the implementation of an electronic medical record system for type 1 diabetes management in Rwanda
by: Nathalie Bille, et al.
Published: (2025-12-01)

Insights Into Genetic Variations of the OCT1 Gene in Metformin Poor Responders Among Bangladeshi Type 2 Diabetic Patients
by: Rokeya Begum, et al.
Published: (2025-01-01)

GLP-1 Receptor Agonists’ Impact on Fertility - A Review
by: Joanna Wojda, et al.
Published: (2025-02-01)

Comparison of GLP-1RAs vs Other Pharmacotherapy for Obesity
by: Andrew Overholser, et al.
Published: (2025-02-01)

Probiotics alleviate painful diabetic neuropathy by modulating the microbiota–gut–nerve axis in rats
by: Ye Jiang, et al.
Published: (2025-02-01)

Metabolic syndrome in type 1 diabetes: higher time above range and glycemic variability revealed by continuous glucose monitoring (CGM)
by: Yayu Fang, et al.
Published: (2025-02-01)

Could hypoxic conditioning augment the potential of mesenchymal stromal cell-derived extracellular vesicles as a treatment for type 1 diabetes?
by: Cathal Patrick Forkan, et al.
Published: (2025-02-01)

Pharmacological regression of atherosclerotic plaque in patients with type 2 diabetes
by: Loredana Bucciarelli, et al.
Published: (2025-03-01)

Thyroid disorders among patients with type II Diabetes Mellitus
by: Mariwan Abdulla Hama Salih
Published: (2019-08-01)

Reducing Your Risk for Type 2 Diabetes: The Power of Food
by: Elena Torna, et al.
Published: (2020-10-01)

Reducing Your Risk for Type 2 Diabetes: The Power of Food
by: Elena Torna, et al.
Published: (2020-10-01)

Process Evaluations of Interventions for the Prevention of Type 2 Diabetes in Women With Gestational Diabetes Mellitus: Systematic Review
by: Iklil Iman Mohd Sa'id, et al.
Published: (2025-02-01)

Author Correction: A prevalent caveolin-1 gene rs926198 variant is associated with type 2 diabetes mellitus in the Thai population
by: Metha Yaikwawong, et al.
Published: (2025-02-01)